The United Laboratories International Holdings Limited (ULIHF)

Market Cap	1.99B -37.7%
Revenue (ttm)	1.75B -15.9%
Net Income	79.38M -82.4%
EPS	0.04 -83.7%
Shares Out	n/a
PE Ratio	23.29
Forward PE	12.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Open	0.9419
Previous Close	0.9603
Day's Range	0.9419 - 0.9419
52-Week Range	0.9419 - 1.7000
Beta	0.29
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 18,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2025, ULIHF's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error